Live Breaking News & Updates on கண்டம் பகுதி

Stay updated with breaking news from கண்டம் பகுதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HollyFrontier Corporation : Reports Quarterly Results

HollyFrontier Corporation : Reports Quarterly Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Rocky Mountain , New Mexico , El Dorado , Rocky Mountains , Canada General , Michael Jennings , Red Giant Oil , Company Securities , Sinclair Transportation Company , Cheyenne Pipeline , Canada Lubricants Inc , Cushing Connect Pipeline Terminal , Exchange Commission , Holly Energy Partners , Osage Pipeline Company , Hollyfrontier Asphalt Company , Sinclair Oil Corporation , Hollyfrontier Corporation , Cheyenne Refinery , Puget Sound Refinery , Specialty Products , Energy Partners , Frontier Corporation , Pacific Northwest , Private Securities Litigation Reform Act ,

Biogen inc (BIIB) Q2 2021 Earnings Call Transcript

Operator
Good morning. My name is Qin, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen s Second Quarter Earnings Call and Financial Update. [Operator Instructions]
Thank you. I would now like to turn the conference over to Mr. Mike Hencke, Director, Investor Relations. Mr. Hencke, you may begin your conference.
Mike Hencke
Director of Investor Relations
Good morning, and welcome to Biogen s second quarter 2021 earnings call. Before we begin, I would encourage everyone to go to the Investors section of biogen.com to find the earnings release and related financial tables, including our GAAP financial measures and a reconciliation of the GAAP to non-GAAP financial measures that we will discuss today. ....

United States , Mike Mcdonnell , Mike Hencke , Chirfi Guindo , Alisha Alaimo , Al Sandrock , Michel Vounatsos , Rachid Izzar , Us Organization , Head Of Research , National Coverage Determination , Committee Of Biogen , Gems Company , Alfred Sandrock Head Of Research , Second Quarter Earnings Call , Chief Executive Officer , Global Product Strategy , Executive Committee , Intercontinental Region , Medicare Advantage , Medicare Administrative Contractors , Clarity Phase , Modified Rankin , ஒன்றுபட்டது மாநிலங்களில் , மைக் மக்டொநெல் , அல் சாண்ட்ராக் ,

Health Care Resilience & Sustainability with Allison Arwady, MD, Cecelia L. Calhoun, MD, Michelle McMurry-Heath, MD & Thomas R. Frieden, MD

Health Care Resilience & Sustainability with Allison Arwady, MD, Cecelia L. Calhoun, MD, Michelle McMurry-Heath, MD & Thomas R. Frieden, MD
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

United States , American University , District Of Columbia , New Zealand , New South Wales , Cecelial Calhoun , Amgen Biosimilars , Ian Thompson , Elise Labott , Sebastian Heath , Allison Arwady , Thomasr Frieden , Tom Frieden , Joe Lieberman , Michelle Mcmurry Heath , Us Centers For Disease , Duke Medical Scientist Training Program , Council On Foreign Relations , Illinois Department Of Public Health , Aspen Institute Health , Radiological Health , Chicago Department Of Public Health , Washington Post , York City Department Of Health , Yale University School Of Medicine , Healthcare Leadership Council ,

Tecfidera Approved in China to Treat Relapsing MS

Tecfidera Approved in China to Treat Relapsing MS
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Yongjun Wang , Rachid Izzar , China First National List Of Rare Diseases , European Union , National Medical Products Administration , Capital Medical University , National Clinical Research Center , Intercontinental Region , Neurological Diseases , Beijing Tiantan Hospital , Capital Medical , First National List , Rare Diseases , ஐரோப்பிய தொழிற்சங்கம் , மூலதனம் மருத்துவ பல்கலைக்கழகம் , தேசிய மருத்துவ ஆராய்ச்சி மையம் , கண்டம் பகுதி , நரம்பியல் நோய்கள் , மூலதனம் மருத்துவ , ரேர் நோய்கள் ,

Biogen Inc.: Biogen Grows Presence in China with the Approval of TECFIDERA (dimethyl fumarate) for the Treatment of Relapsing Multiple Sclerosis

(1)
TECFIDERA was approved under the National Medical Products Administration priority review process evaluating therapies with urgent clinical needs
More than 500,000 individuals worldwide living with multiple sclerosis (MS) have been treated with TECFIDERA, which has a well-established safety and efficacy profile
Biogen s expansion in China now includes treatment options approved for relapsing MS and spinal muscular atrophy
CAMBRIDGE, Mass., April 15, 2021(Nasdaq: BIIB) today announced that China s National Medical Products Administration (NMPA) has approved TECFIDERA
(dimethyl fumarate) for the treatment of relapsing multiple sclerosis (MS). First introduced in 2013, TECFIDERA has demonstrated a well-established safety and efficacy profile with more than 10 years of data from clinical trials and real-world experience. ....

United Kingdom , David Caouette , Mike Hencke , Walter Gilbert , Charles Weissmann , Heinz Schaller , Kenneth Murray , Rachid Izzar , Chinese Medical Association , Chinese Society Of Neurology , Exchange Commission , Promotive Association For , China National Medical Products Administration , China International Exchange , Royal College , National Medical Products Administration , Intercontinental Region , Third Batch , New Overseas Drugs Urgently Needed , Clinical Settings , Drug Evaluation , Important Safety Informationand , Prescribing Information , Patient Informationfor , Nobel Prize , Today Biogen ,